QA: BALCHEM CORP in us_medicinal_products/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2017_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 226,490,000
1 LiabilitiesCurrent 101,008,000
2 remainder_Liabilities 100,095,000
3 AssetsCurrent 188,442,000
4 AssetsNoncurrent 7,135,000
5 PropertyPlantAndEquipmentNet 165,754,000
6 Goodwill 587,295,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 455,041,000
9 ResearchAndDevelopmentExpense 7,325,000
10 remainder_Expenses 34,227,000
11 remainder_Revenues 553,204,000
12 remainder_NetIncome -639,000
13 remainder_ComprehensiveNetIncome -1,735,000
  yvar yval
0 Liabilities 427,593,000
1 Assets 948,626,000
2 Expenses 496,593,000
3 Revenues 553,204,000
4 StockholdersEquity 521,033,000
5 NetIncome 55,972,000
6 ComprehensiveNetIncome 55,104,500
7 BaseVar 1,214,195,000
8 EconomicCapitalRatio 0.724

Edgar->Model Mapping

Feature Distribution